Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The NHS North Central London ICB has awarded a contract under the Health Care Services (Provider Selection Regime) Regulations 2023, for the provision of in vitro fertilisation (IVF) services. The awarded contract, titled "Herts and Essex Fertility - IVF Spot Purchase NCL ICB," has been issued to HERTS and ESSEX FERTILITY CENTRE LIMITED. This contract award is part of a limited procurement method, classified under the services category.

The procurement process was completed without prior publication of a call for competition, as it falls outside the scope of the Public Contracts Regulations 2015. The contract was signed on 19th September 2025, and the delivery is intended for the UKH2 region, encompassing areas within Hertfordshire and Essex. This tender creates a significant opportunity for businesses specialising in healthcare services, particularly those focused on reproductive health and IVF treatments.

The successful contractor, already established as an SME, highlights the opportunities for similar small and medium-sized enterprises to participate in specialised health service provision. The use of a direct award under the Provider Selection Regime simplifies the application process, making it more accessible to businesses looking to expand their footprint in providing niche healthcare solutions. Businesses with expertise in healthcare service delivery, regulatory compliance, and patient-centred care models are well-suited to compete in tenders of this nature.